Hemab Therapeutics Holdings Common Stock Overview

Hemab Therapeutics Holdings Common Stock Net Income

Hemab Therapeutics Holdings Common Stock net income — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$24.15M

As of Jun 2026

Annual Net Income (TTM)

N/A

Average Net Income (Comparison Companies)

Net Income History

Net Income Comparison

Annual Net Income Growth Rate (%)

Annual Net Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin

Hemab Therapeutics Holdings Common Stock (COAG) FAQ

Stockcircle tracks net income for Hemab Therapeutics Holdings Common Stock (COAG), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Net Income page is built for Hemab Therapeutics Holdings Common Stock's historical net income trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use net income as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main COAG overview so you can move from this figure to the surrounding analysis quickly.